The Net Margin of Cullinan Therapeutics, Inc. (CGEM) is
-346.20%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2024-12-31 |
-346.20%
|
| 2023-12-31 |
-346.20%
|
| Ticker |
Name |
Value |
|
VBIV
|
VBI Vaccines Inc
|
-1069.29%
|
|
KRYS
|
Krystal Biotech, Inc.
|
52.64%
|
|
KURA
|
Kura Oncology, Inc.
|
-412.95%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
-314.90%
|
|
PAND
|
Pandion Therapeutics Inc
|
-2262.36%
|
|
FPRX
|
Five Prime Therapeutics Inc
|
-639.91%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
NKTX
|
Nkarta, Inc.
|
-17566.67%
|
|
OCGN
|
Ocugen, Inc.
|
-1537.41%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
DMTK
|
DermTech Inc
|
-659.57%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
ALEC
|
Alector, Inc.
|
-679.16%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
-292.08%
|
|
KRON
|
Kronos Bio LLC
|
-874.08%
|
|
ADCT
|
Adc Therapeutics Ltd
|
-175.31%
|
|
CYTK
|
Cytokinetics, Incorporated
|
-891.60%
|
|
GBIO
|
Generation Bio Co
|
-661.91%
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
-4.29%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
MYOV
|
Myovant Sciences Ltd
|
-89.18%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
ZYME
|
Zymeworks Inc.
|
-76.56%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
ALVR
|
Allovir Inc
|
-14023.53%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|